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ABSTRACT
Objective: This study aimed to isolate fungi having antibacterial activity from pharmaceutical site soil sample and production of antibacterial agents 
by solid and submerged state fermentation under optimized conditions. Antibacterial activity of laboratory isolated and produced antibacterial agent 
was compared with other commercialized antibiotics to check the efficiency of laboratory produced antibacterial agent.
Methods: For isolation and characterization of fungal isolates American Public Health Association standard was followed. Antibacterial activity was 
determined using disc diffusion and agar disc diffusion method.
Results: On the basis of morphological and microscopic characteristics six fungal isolates belongs to four different genus species, i.e., Aspergillus sp. 
(F1, F2, F3), Penicillium sp. (F4), Rhizopus sp. (F5), and Fusarium sp. (F6), and they were tested against six bacterial isolates, i.e., Streptococcus sp. (B1), 
Bacillus sp. (B2), Staphylococcus sp. (B3), Bacillus sp. (B4), Bacillus sp. (B5), and Enterococcus sp. (B6). Except B4 all bacterial isolates growth were 
inhibited by fungal isolates. Under optimized conditions maximum zone of inhibition, i.e., 78 mm against B1 and B5 shown by F1 and F6 at 2% and 1% 
glucose concentration, respectively, at 10 pH. When comparison was made between commercialized antibiotics and lab produced antibacterial agents, 
it was observed lab produced antibacterial agent was more efficient in terms of zone of inhibition.
Conclusion: Lab isolated and produced antibacterial agents were more efficient than commercialized antibiotics. This study demonstrated that lab 
isolated antibacterial agents isolated from six fungal isolates seems to be a stable and potent antibacterial and can be used as alternative to expensive 
commercialized antibiotics.
Keywords: Antibacterial, Fungi, Disc diffusion, Fermentation.
INTRODUCTION
Antibiotic is a medicinal substance used to treat infections caused by 
microbes that can cause disease to higher level of eukaryotic organisms. 
Antibiotic functions to break down the bacterial cells that cause certain 
disease because antigenic substances are present on the cell wall of 
bacteria. Microorganisms are the most potential source for production 
of natural therapeutic agents [1]. In fact, to maintain their niche and 
territory, bacteria produce antibiotic as secondary metabolite. There 
are few classes of microorganisms that can be used as sources for 
clinically useable antibiotics [2].
Today at global level health care is facing the problem of emergence 
of multi-resistant bacteria thus threat of epidemics and pandemics [3] 
and became a major global health problem [4,5]. Several factors have 
favored this scenario such as extensive and often inappropriate use 
of antibiotics, poor hygienic conditions, emigration/immigration 
of travelers, increased numbers of immunocompromised patients, 
and delay in diagnosis of infections [6]. The tremendous increase in 
antibiotics resistant bacterial species leads to the invention of new 
sources of antibiotics through microorganisms such as bacteria, fungi, 
and actinomycetes [7]. The antibiotics produced by microbes have been 
gaining importance by many researchers. Soil is considered one of the 
most suitable habitats or environments for microbial growth. The pace 
of development of genuinely new antimicrobial agent is disappointingly 
slow.
For the human health and nutrition fungi are well known to produce 
both beneficial and deleterious natural agents and continue to 
be explored as useful sources of natural antimicrobial agents. In 
comparison to plants, microorganisms are highly diverse but narrowly 
explored. Till date, only about 1% of bacteria and 5% of fungi have been 
characterized while rest remains unexplored for their contribution 
to the human welfare [8]. In recent years, the isolation of fungi from 
soil and screening of antimicrobial activity has gained more attention. 
Present study worked on isolation of fungi having antibacterial activity 
and compared antibacterial activity with commonly prescribed 
antibiotics so antibacterial agent from fungi having high activity 
against bacteria will be used as feasible and economical option to 
commercialized antibiotics.
Based on the above-mentioned literatures, this study is an attempt to 
isolate fungi from pharmaceutical site soil sample and to investigate the 
antimicrobial activity of certain soil microorganisms, i.e., fungi isolated 
from the soil sample. Crude extract of fungi was prepared and was tested 
for antibacterial activities against a set of test bacteria. To evaluate 
their antibacterial efficiency, antibacterial activity was compared w`ith 
commercially available antibiotics. Further, antibacterial agent from 
isolated fungi was produced by solid state and submerged fermentation.
METHODS
Procurement of wastewater samples
Sampling of soil sample was done from pharmaceutical site according 
to standard procedures from American Public Health Association 
(1989) [9].
Procurement of chemicals, media, reagents and instruments
All the chemicals and analytical reagent grade were commercially 
obtained from HIMEDIA®, Loba Chemie®, SRL® (Sisco Research 
Laboratories) and Qualigens® and used as received without further 
modification. Double-distilled water was filtered through a Millipore 
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membrane filter before being used. The instruments were purchased 
from Remi Equipment Ltd., Esico, M.S. Electronics India Pvt. Ltd. and 
Bio-age equipment and services.
Isolation of bacterial isolates
Soil sample bacteria were isolated by Koch method based on the 
serial dilution and spreading on nutrient agar. From the individual 
colonies resulted on the media, bacterial pure cultures were obtained 
by inoculation in test tubes with sloping medium surface at 37±1.0°C, 
48 hrs.
Isolation of fungal isolates
Dairy wastewater fungi were isolated by Koch method based on 
the serial dilution and spreading on potato dextrose agar. From the 
individual colonies resulted on the media, fungal pure cultures were 
obtained by inoculation in test tubes with sloping medium surface at 
25±1.0°C, 72 hrs.
Inoculum preparation
Each bacterial isolate with 0.1 ml suspension (3.1 × 105 CFU/ml) was 
inoculated in 100 ml inoculum medium. The flasks were kept on rotary 
shaker at 150 rpm for 24 hrs at 37°C. Similarly, 0.1 ml suspension of 
fungal isolate was inoculated in 100 ml inoculum medium. The flask 
was kept on rotary shaker at 150 rpm for 3 days at 25°C.
To study the biodegradation efficiency of the microbial isolates, 
biomass of actively growing cells was prepared. For the same, each 
bacterial isolate was grown on 50 ml nutrient broth and 50 ml potato 
dextrose broth for fungi at 150 rpm on rotary shaker at 32°C/25°C 
for 24-72 hrs. Actively, growing bacterial culture of each isolate was 
centrifuged at 10,000 rpm for 10 minutes to get wet pellet of each 
isolate and pellet was washed thrice with sterile distilled water. The 
pellet was resuspended in sterile deionized water till turbidity reaches 
at or above that of McFarland 0.5 standard [10].
Cultivation for screening and isolation of secondary metabolites
Each fungal isolate was inoculated into a 1000 ml Erlenmeyer flask 
containing 300 ml of PDB media. Depending on the fungal growth, 
cultures on liquid medium were incubated for 3-4 weeks. The 
fermentation was brought to an end by adding 250 ml ethyl acetate to 
the culture flask and standing closed for at least 24 hrs.
Extraction of fungal liquid cultures
About 250 ml ethylacetate were added to each Erlenmeyer flask 
containing 300 ml culture medium and left overnight to stop cell growth. 
Crude extract of fungal isolates prepared according to Kalyanasundaram 
et al. [11], and crude extracts were subjected to antimicrobial assays.
Screening of fungal isolates for antibacterial activity
Antagonistic assay for fungal extract against bacteria
Antagonistic assay was done by an agar disk diffusion and disk diffusion 
method. Isolated fungal extract was tested for the antibacterial activity. 
Bacteria were spread on Mueller-Hinton agar (MHA) plates. Then, disks 
(dipped in crude fungal extract) were placed on media and 2 mm agar 
disk were also placed on media. Antagonistic activity was detected after 
an incubation of 24-48 hrs at 30°C. The presence of zone clearance on 
agar plates was used as an indicator for the antibacterial activity. The 
strains which showed the maximum zone of clearance was chosen for 
further study [11].
Identification of potential fungal isolates
For characterization of the morphology of fungal isolates, slides 
prepared from cultures were stained with lactophenol cotton blue 
reagent and examined under light microscope [11].
Identification of test bacterial isolates
Characterization of unknown bacterial cultures
The identification and characterization of unknown bacteria were done 
on the basis of microscopic observation (morphology and arrangement 
of cells, cultural growth characteristics on agar), Gram-stain and various 
biochemical tests as given by Bergey’s (1984) manual of determinative 
bacteriology [12] and online ABIS software.
Submerged fermentation
Fungal isolates inoculum was introduced aseptically into each sterile 
flask containing the following ingredients (g/L): Glucose (20), 
KNO3 (2.0), K2HPO4 (0.8), MgSO4·7H2O (0.7), and KCl (0.5). The pH 
was adjusted at 7.0 before sterilization. After 5 days of incubation at 
30°C. Filtration was carried out through cotton wool and followed by 
centrifugation at 5000 rpm for 15 minutes [13].
Extraction
The culture filtrates were extracted twice with n-butanol and the 
pooled solvent extracts were evaporated to dryness under vacuum to 
yield a crude residue.
Optimization of media parameters for efficient biosynthesis of 
antibacterial agent
Incubation pH
Effect of different pH ranging from 4, 7 and 10 was examined on the 
biosynthesis of the selected fungal isolates.
Glucose concentration
Biosynthesis of antibacterial agent by the selected fungal isolates was 
studied at different glucose concentrations such as 1%, 2%, and 3%.
Solid state fermentation
The static experiments were conducted in Erlenmeyer flasks containing 
10 g wheat bran (particle size 500 µm-1 mm) as substrate. 1% 
ammonium sulfate was added to the substrate as additional nutrient. 
After sterilization inoculated the substrate with 1 ml inoculum and 
moistened with appropriate amount of autoclaved seawater so that the 
final moisture content was 60% (w/v). Fermentation was carried out 
for 7 days at 30°C. After incubation, the extraction and antibiotic assays 
were carried out.
Extraction of antibiotic (crude extract)
Extraction of antibiotic was done by the addition of 50 ml distilled water 
to the fermented substrate (10 g). Filtration was done using cheese 
cloth and the filtrate was subjected to centrifugation at 10,000 rpm for 
10 minutes. The supernatant was used for antibiotic assay [14].
Compare of antibacterial activity of fungal isolates with 
commercialized antibacterial agents on the basis of zone of 
inhibition
Determination of minimum inhibitory concentration value was carried 
out using disk diffusion method. Antibacterial agent disk (fungal 
isolates) was placed onto the MHA media inoculated with test bacteria. 
Seven commercialized antibiotic discs, i.e., erythromycin, fluconazole, 
voriconazole, cefotaxime, ceftriaxone, cefixime, and nalidic acid were 
also placed onto the MHA media inoculated with test bacteria. The plate 
was incubated at 30°C for 24-48 hrs. The diameter of the inhibition 
zone formed around the disc was measured [2].
Statistical analysis
The results are presented as the means±standard deviation [15].
RESULTS AND DISCUSSION
Sample collection, isolation, and identification of fungi and 
bacteria at genus level
A systematic study about the fungal biodiversity in pharmaceutical 
site soil was carried out to evaluate their capacity to produce the 
bioactive compound. A total of six fungi were isolated from soil sample 
by spreading and streaking method using potato dextrose agar media 
for cultivation. Six bacteria were also isolated from soil sample by 
spreading and streaking method using nutrient agar media and used 
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as test organisms on which fungi were screened for their antifungal 
activity. The colony morphology and microscopic characterization of 
each bacterial isolate and fungal isolate are illustrated in Table 1, Table 
2 and Table 3. Dos Santos et al. [6] isolated 65 fungi from the leaves 
of Indigofera suffruticosa and screened them for their antimicrobial 
activity. Svahn et al. [3] isolated 61 fungal isolates from highly antibiotic-
contaminated river sediments and their screened fungal isolates for 
their antibacterial activity.
Screening of fungal isolates having antibacterial property
Antibacterial activity of crude extract by agar disc diffusion and 
paper disc method
The antibacterial activity at concentration of 25 mg/ml of ethyl acetate 
extracts of fungi was tested against six bacteria, i.e., B1, B2, B3, B4, 
B5, B6 had shown broad-spectrum activity which has been reported 
in Table 4. The crude extract of F1, F2, F3, F4, F5, F6 produced the 
highest zone of inhibition 76, 33, 60, 72, 69, and 77 mm, respectively, 
against bacteria B2, B5 and B6, respectively. The crude extract F6 from 
ethylacetone solvent has shown the highest zone of inhibition of 77 mm 
against B2.
Solid state and submerged fermentation for production of 
antibacterial agent from fungal isolates
Solid-state fermentation
Optimization of antibacterial agent production
Optimization for maximum production of antibacterial agent was done 
at different incubation time, i.e., 2, 4, 6 days. The results obtained from 
the 6 day, solid-state fermentation is the best. This contains maximum 
amount of supernatant, which is responsible for the antibacterial 
activity.
Maximum antibacterial agent concentration as shown in Table 5 
was achieved after 6 days of incubation. Least antibacterial agent 
concentration was observed after 2 days of incubation. Maximum 
antibacterial agent was produced by F4 followed by F1, F5, F3, F6, 
and F2.
Test for sensitivity
Six bacteria were tested for their sensitivity of fungal extract. The 
antibacterial potency was determined by the agar disc diffusion 
method. Table 6 shows diameters of inhibition zones exerted by the 
Table 1: Morphological and microscopic analysis of fungal isolates
Isolates Colony characteristics Zonation Sporulation Tentative fungi
F1 Velvety thick, creamish white Radially furrowed Moderate Aspergillus sp.
F2 Velvety, white with typical black spores Heavily furrowed on the reverse Heavy Aspergillus sp.
F3 Velvety, light yellow With venation like radial furrows Nil Aspergillus sp.
F4 Powdery, olivaceous green with sterile white margin Radially furrowed Heavy Penicillium sp.
F5 Cottony, white Radially furrowed Moderate Rhizopus sp.
F6 Floccose, magenta pink With concentric zones of dark and light 
reddish coloration
Poor Fusarium sp.
Table 2: Morphological and microscopic analysis of bacterial isolates
Isolates Colony characteristics Gram 
reaction
B1 Branching growth pattern with yellowish white appearance Positive 
B2 Circular, convex, smooth, golden yellow Positive 
B3 Small, round, regular, red color pigmented Positive
B4 Small, circular, regular, pale yellow color pigmentation Positive
B5 Large, irregular, greenish yellow fluorescent colonies Positive
B6 Rod shaped, moist colony with irregular edges Negative
Table 3: Biochemical characterization of bacterial isolates
Isolates Catalase Citrate MR VP Indole Nitrate H2S Tentative bacteria
B1 + + - - - + - Streptococcus sp. 
B2 + + + - - + - Bacillus sp.
B3 + - - + - + - Staphylococcus sp.
B4 + + - - - + - Bacillus sp.
B5 + - - - - + - Bacillus sp.
B6 - - - + - + - Enterococcus sp.
+: Present; -: Absent, MR: Methyl red, VP: Voges Proskauer
Table 4: Antibacterial activity shown by fungal isolates against test bacteria
Isolates Zone of inhibition (mm) shown by fungal isolates against test bacteria
F1 F2 F3 F4 F5 F6
BI1 24(±3) 0(±0) 40(±3.8) 36(±5.3) 36(±5) 17(±4.5)
BI2 60(±5) 0(±0) 60(±2.7) 3(±0.5) 3(±0.5) 26(±2.2)
BI3 76(±2.9) 23(±2.4) 2(±0) 0(±0) 0(±0) 0(±0)
BI4 0(±0) 0(±0) 0(±0) 0(±0) 0(±0) 0(±0)
BI5 0(±0) 33(±4.2) 46(±4.2) 72(±4.5) 69(±5.4) 77(±5.9)
BI6 10(±1.2) 13(±1.1) 0(±0) 10(±2.2) 62(±4.8) 45(±3.8)
*Each value is mean of three determination, *Values in parenthesis indicate standard deviation
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various extracts toward challenged bacteria. Clear zones against BI1, 
BI2, BI3, BI5, BI6 but in BI4 showed the hazy zones, i.e., not clear.
As compared to values of zone of inhibition (mm) of bacteria shown by 
six fungal isolates illustrated in Table 4 with the values given in Table 6, 
it was observed that under optimized treatment condition increment 
in zone of inhibition was noticed. From Table 4, it was observed that 
F1 maximally inhibit bacteria growth around 76 mm while under 
optimized condition 77 mm. F2 maximally inhibit bacteria growth 
around 33 mm while under optimized condition 34 mm. F3 maximally 
inhibit bacteria growth around 60 mm while under optimized condition 
61 mm. F4 maximally inhibit bacteria growth around 72 mm while 
under optimized condition 74 mm. F5 maximally inhibit bacteria growth 
around 69 mm while under optimized condition 70 mm. F6 maximally 
inhibit bacteria growth around 77 mm while under optimized condition 
78 mm.
Submerged state fermentation
Optimization for maximum production of antibacterial agent was 
done at different pH values, i.e., 4, 7 and 10 and at different glucose 
concentrations, i.e., 1%, 2% and 3%. The results obtained from the pH 4, 
7, 10 and glucose concentration 1%, 2%, 3% submerged fermentation 
is the best. This contains maximum amount of supernatant, which is 
responsible for the antibacterial activity.
It was clear from Table 7, six fungal isolates produced maximum 
antibacterial agent at variable pH range. Maximum antibacterial agent 
produced by F1 at pH 10, i.e., 0.24 while F2 at pH 4, i.e., 0.09. Maximum 
antibacterial agent produced by F3 at pH 10, i.e., 0.16 while F4 at pH 4, 
i.e., 0.76. Maximum antibacterial agent produced by F5 at pH 4, i.e., 0.14 
while F6 at pH 10, i.e., 0.32. Least antibacterial agent concentration 
produced by F1 at pH 7, i.e., 0.01 while F2 at pH 10, i.e., 0.03. Least 
antibacterial agent concentration produced by F3 at pH 4, i.e., 0.01 while 
F4 at pH 7, i.e., 0.07. Least antibacterial agent concentration produced by 
F5 at pH 7, i.e., 0.07 while F6 at pH 4, i.e., 0.01. Maximum antibacterial 
agent was produced by F4 followed by F6, F1, F3, F5 and F2.
As observed from Table 8, six fungal isolates produced maximum 
antibacterial agent at variable glucose concentration. Maximum 
antibacterial agent produced by F1 at 2% glucose concentration, 
i.e., 0.90 while F2 at 1% glucose concentration, i.e., 0.15. Maximum 
antibacterial agent produced by F3 at 1% glucose concentration, 
i.e., 0.38 while F4 at 1% glucose concentration, i.e., 0.08. Maximum 
antibacterial agent produced by F5 at 1% glucose concentration, 
i.e., 0.09 while F6 at 1% glucose concentration, i.e., 0.44. Least 
antibacterial agent concentration produced by F1 at 3% glucose 
concentration, i.e., 0.15 while F2 at 3% glucose concentration, i.e., 0.00. 
Least antibacterial agent concentration produced by F3 at 2% glucose 
concentration, i.e., 0.07 while F4 at 2% glucose concentration, i.e., 0.02. 
Least antibacterial agent concentration produced by F5 at 3% glucose 
concentration, i.e., 0.05 while F6 at 2% glucose concentration, i.e., 0.09. 
Maximum antibacterial agent was produced by F1 followed by F6, F3, 
F2, F5 and F4.
Test for sensitivity
Six bacteria were tested for their sensitivity of fungal extract. The 
antibacterial potency was determined by the agar disc diffusion 
method. Table 9 shows diameters of inhibition zones exerted by the 
various extracts toward challenged bacteria. Clear zones against BI1, 
BI2, BI3, BI5, BI6 but BI4 in showed the hazy zones, i.e., not clear.
As compared to values of zone of inhibition (mm) of bacteria shown by 
six fungal isolates illustrated in Table 4 with the values given in Table 9, 
it was observed that under optimized treatment condition increment 
in zone of inhibition was noticed. From Table 4, it was observed that 
F1 maximally inhibit bacteria growth around 76 mm while under 
optimized condition 78 mm. F2 maximally inhibit bacteria growth 
around 33 mm while under optimized condition 37 mm. F3 maximally 
inhibit bacteria growth around 60 mm while under optimized condition 
64 mm. F4 maximally inhibit bacteria growth around 72 mm while under 
optimized condition 75 mm. F5 maximally inhibit bacteria growth around 
69 mm while under optimized condition 73 mm. F6 maximally inhibit 
bacteria growth around 77 mm while under optimized condition 78 mm.
Table 5: Antibacterial agent concentration at variable incubation period 2, 4 and 6 days
Incubation period 
(days)
Optical density at 600 nm
F1 F2 F3 F4 F5 F6
2 0.10 0 0.07 0.9 0 0
4 0.25 0.04 0.18 1.18 0.27 0.08
6 0.42 0.11 0.33 2.29 0.41 0.19
Table 6: Antibacterial activity shown by fungal isolates against test bacteria under optimized condition
Isolates Zone of inhibition (mm) shown by fungal isolates against test bacteria
F1 F2 F3 F4 F5 F6
BI1 25((±5.2) 0(±0) 42(±3.2) 37(±3.5) 39(±3.9) 18(±2.2)
BI2 62(±4.5) 0(±0) 61(±5.2) 7(±1.5) 7(±1.2) 27(±2.8)
BI3 77(±5) 25(±2.5) 8(±0) 0(±0) 0(±0) 0(±0)
BI4 0(±0) 0(±0) 0(±0) 0(±0) 0(±0) 0(±0)
BI5 0(±0) 34(±4.4) 48(±3.5) 74(±5.5) 70(±5.8) 78(±5.6)
BI6 12(±2.4) 14(±1.4) 0(±0) 12(±4.6) 63(±4.9) 46(±3.3)
*Each value is mean of three determination, *Values in parenthesis indicate standard deviation
Table 7: Antibacterial agent concentration at variable pH range 4, 7 and 10
pH Optical density at 600 nm
F1 F2 F3 F4 F5 F6
4 0.08 0.09 0.01 0.76 0.14 0.01
7 0.01 0.07 0.09 0.07 0.07 0.09
10 0.24 0.03 0.16 0.11 0.09 0.32
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Bisht et al. [16] isolated five fungal endophytes from living symptomless 
needle of Cupressus torulosa D. Don and characterized as such as 
Aspergillus sp., Fusarium sp., Cladosporium sp., Curvularia sp., and 
Diaporthe sp. in which, only Cladosporium sp. (PCTS23) and Curvularia 
sp., two (WCTS21) endophytic fungal isolates were able to show strong 
antagonism activity against fungal pathogen. The WCTS21 crude extract 
produced the highest zone of inhibition 12 mm for Staphylococcus 
aureus, whereas crude extract of PCTS23 has shown the highest zone of 
inhibition of 10 mm against S. aureus.
Similarly, Sandhu et al. [17] isolated and screened ten fungal isolates, 
viz., Aspergillus fumigates, Aspergillus japonicas, Aspergillus niger, 
Fusarium semitectum, Curvularia pallescens, Phoma hedericola, 
Alternaria tenuissima, Fusarium solani, Drechslera australien, and 
Aspergillus repens from medicinal plant Ricinus communis for their 
antibacterial activity against six human pathogenic bacterial strains 
Bacillus subtilis, Enterococcus sp., Klebsiella pneumoniae, Escherichia 
coli, Salmonella typhimurium, and S. aureus.
Desale and Bodhankar [18] isolated seventeen fungi, i.e., Colletotrichum 
gloeosporioides Penz, Phomopsis archeri B. sutton, Aspergillus flavus 
gr., Nigrospora sphaerica (Sacc.) Mason, Nonsporulating dematiaceous 
form, Colletotrichum gloeosporioides Penz., Alternaria raphani JW 
Groves, Penicillium sp., Mucor hiemalis Wehmer, Monodictys paradoxa 
(Corda) Hughes, Nigrospora state of Khuskia oryzae H.J. Hudson from 
different parts of Vitex negundo L. Antibacterial activity of fungal 
isolates were screened against six bacteria, viz., E. coli (NCIM No. 2345), 
S. typhimurium (NCIM No. 2501), Bacillus cereus (NCIM No. 2155), 
S. aureus (NCIM No. 2079), K. pneumoniae (NCIM No. 2706), and B. 
subtilis (NCIM No. 2063). The crude extract of seventeen fungal isolates 
with hexane, ethyl acetate and methanol were screened for their 
antimicrobial potential. The extract of P. archeri B. sutton in ethyl acetate 
showed significant antimicrobial activity against E. coli, S. typhimurium, 
B. cereus, B. subtilis, K. pneumoniae, and S. aureus. The antimicrobial 
activity was highest against E. coli (24 mm), followed by S. typhimurium 
(22 mm) and B. cereus (16 mm). The hexane and methanol extracts 
showed moderate activity against all the pathogenic organisms.
Comparative analysis of antibacterial activity of fungal isolates 
and commercialized antibiotics
In this study, seven commercialized antibiotics, i.e., erythromycin 
(ER), fluconazole (FZ), voriconazole (VZ), cefotaxime (CT), ceftriaxone 
(CX), cefixime (CF), and nalidic acid (NA) were used against six test 
bacteria and zone of inhibition was observed after 24, 48 and 72 hrs of 
incubation period. Zone of inhibition was shown in Table 10.
When comparison was made between antibacterial agent produced 
from lab isolated fungal strains and commercialized antibiotics, it 
was observed except bacterial isolate BI1 all bacterial strains were 
inhibited by all fungal isolate’s antibacterial agent more efficiently as 
compared to commercialized antibiotics. BI1 showed maximum zone of 
inhibition against antibiotic cefotaxime, i.e., 40 mm while against fungal 
isolate antibacterial agent, i.e., 45 mm. BI2 showed maximum zone of 
inhibition against antibiotic erythromycin, i.e., 55 mm while against 
fungal isolate antibacterial agent, i.e., 65 mm. BI3 showed maximum 
zone of inhibition against antibiotic erythromycin, i.e., 48 mm while 
against fungal isolate antibacterial agent, i.e., 78 mm. BI4 showed 
maximum zone of inhibition against antibiotic ceftriaxone, i.e., 27 mm. 
BI5 showed maximum zone of inhibition against antibiotic nalidic acid, 
i.e., 40 mm while against fungal isolate antibacterial agent, i.e., 78 mm. 
BI6 showed maximum zone of inhibition against antibiotic ceftriaxone, 
i.e., 28 mm while against fungal isolate antibacterial agent, i.e., 65 mm.
CONCLUSION
This study raises the possibility of exploring fungal species having 
antibacterial activity and used them as alternative to commercialized 
antibiotics. Furthermore, our observations indicate that fungi from 
Table 10: Antibacterial activity shown by commercialized antibiotics against test bacteria
Isolates Zone of inhibition (mm) shown by fungal isolates against test bacteria
ER FZ VZ CT CX CF NA
BI1 24 0 0 40 31 0 27
BI2 55 52 0 25 28 0 25
BI3 48 0 0 46 46 22 49
BI4 0 0 0 17 27 10 15
BI5 11 0 0 19 27 0 40
BI6 17 0 0 15 28 0 0
ER: Erythromycin, FZ: Fluconazole, VZ: Voriconazole, CT: Cefotaxime, CX: Ceftriaxone, CF: Cefixime, NA: Nalidic acid
Table 8: Antibacterial agent concentration at variable glucose concentrations 1%, 2% and 3%
Glucose 
concentration (%)
Optical density at 600 nm
F1 F2 F3 F4 F5 F6
1 0.31 0.15 0.38 0.08 0.09 0.44
2 0.90 0.10 0.07 0.02 0.08 0.09
3 0.15 0.00 0.24 0.05 0.05 0.20
Table 9: Antibacterial activity shown by fungal isolates against test bacteria under optimized condition
Isolates Zone of inhibition (mm) shown by fungal isolates against test bacteria
F1 F2 F3 F4 F5 F6
BI1 27(±3.2) 0(±0) 45(±5.2) 39(±3.2) 42(±2.2) 20(±2.2)
BI2 65(±6.4) 0(±0) 64(±6.7) 10(±1.2) 9(±0.8) 30(±3.5)
BI3 78(±6.2) 27(±3.2) 12(±2.2) 0(±0) 0(±0) 0(±0)
BI4 0(±0) 0(±0) 0(±0) 0(±0) 0(±0) 0(±0)
BI5 0(±0) 37(±2.2) 51(±3.2) 75(±4.2) 73(±6.8) 78(±6.5)
BI6 15(±1.2) 16(±1.2) 0(±0) 14(±1.2) 65(±4.2) 49(±4.2)
*Each value is mean of three determination, *Values in parenthesis indicate standard deviation
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pharmaceutical soil sample have pharmaceutical potential as they 
produce antibacterial compounds and that the medicinal properties of 
these fungi may be a consequence of the capacity to produce biologically 
active secondary metabolites. Further studies are now needed to 
identify the active compounds produced to discover new drugs with 
antibacterial activity.
ACKNOWLEDGMENT
The authors express gratitude to Principal, Head Department of 
Biotechnology, SGGS College and Panjab University, for their valuable 
support during the entire study.
REFERENCES
1. Pannapa P, Pattra S. Antimicrobial and enzyme activity produced 
by Bacillus Spp. Isolated from soil. Int J Pharm Pharm Sci 
2017;9(3):205-10.
2. Lihan S, Choon YK, Hua NK, Wasli ME. Screening for antimicrobial 
activity of fungi in soil samples collected from Kubah National Park. 
Int J Sci Technol Res 2014;3(2):1-16.
3. Svahn KS, Göransson U, El-Seedi H, Bohlin L, Larsson DJ, Olsen B, 
et al. Antimicrobial activity of filamentous fungi isolated from 
highly antibiotic-contaminated river sediment. Infect Ecol Epidemiol 
2012;2:1-6.
4. Girish K. Antimicrobial activities of Lantana camara Linn. Asian J 
Pharm Clin Res 2017;10(3):57-67.
5. Kavitha R, Dhamodharan N, Dhivya C. Screening, isolation, and 
antibacterial activity of antibiotic producing bacteria obtained from 
saprophytic soil samples. Asian J Pharm Clin Res 2017;10(3):92-6.
6. Dos Santos IP, da Silva LC, da Silva MV, de Araújo JM, Cavalcanti 
Mda S, Lima VL. Antibacterial activity of endophytic fungi from 
leaves of Indigofera suffruticosa Miller (Fabaceae). Front Microbiol 
2015;6:350.
7. Sheikh HM. Antimicrobial activity of certain bacteria and fungi isolated 
from soil mixed with human saliva against pathogenic microbes causing 
dermatological diseases. Saudi J Biol Sci 2010;17(4):331-9.
8. Chioma N, Njoku EN, Pharamat T. antimicrobial activity of secondary 
metabolites of fungi isolated from leaves of bush mango. J Next Gener 
Seq Appl 2016;3(3):1-6.
9. Sonune NA, Garode AM. Bioremediation potential of bacterial 
isolates for municipal wastewater treatment. Curr World Environ 
2015;10(2):619-25.
10. Porwal HJ, Mane AV, Velhal SG. Biodegradation of dairy effluent by 
using microbial isolates obtained from activated sludge. Water Resour 
Ind 2015;9C:1-15.
11. Kalyanasundaram I, Nagamuthu J, Muthukumaraswamy S. 
Antimicrobial activity of endophytic fungi isolated and identified from 
salt marsh plant in Vellar Estuary. J Microbiol Antimicrob 2015;7(2):13-
20.
12. Bhattacharya C, Harsha P, Gupta S, Royd SO. Isolation and 
characterization of bacterial isolates from agricultural soil at durg 
district. Indian J Sci Res 2014;4(1):221-6.
13. Atta HM. Biochemical studies on antibiotic production from 
Streptomyces sp: Taxonomy, fermentation, isolation and biological 
properties. J Saudi Chem Soc 2015;19(1):12-22.
14. Smitha SL, Philip R. Antibiotic production by a marine fungus 
Penicillium citrinum S36 through solid state fermentation: Optimization 
by response surface methodology. Int J Res Biomed Biotechnol 
2014;4(1):6-13.
15. Rigoberto VG, Rodolfo AV, Vera LP.  Chemical compounds and 
biological activity of an extract from Bougainvillea x buttiana (var. 
Rose) Holttum and Standl. Int J Pharm Pharm Sci 2017; 9(3): 42-6.
16. Bisht RI, Sharma D, Agrawal PK. Antagonistic and antibacterial activity 
of endophytic fungi isolated from needle of Cupressus torulosa D. Don. 
Asian J Pharm Clin Res 2016;9(3):282-8.
17. Sandhu SS, Kumar S, Aharwal RP. Isolation and Identification of 
endophytic fungi from Ricinus communis Linn. And their antibacterial 
activity. Int J Res Pharm Chem 2014;4(3):611-8.
18. Desale MG, Bodhankar MG. Antimicrobial activity of endophytic 
fungi isolated from Vitex negundo Linn. Int J Curr Microbiol Appl Sci 
2013;2(12):389-95.
19. Rigoberto VG, Rodolfo AV, Vera LP. Chemical compounds and 
biological activity of an extract from Bougainvillea x buttiana 
(var. Rose) Holttum and Standl. Int J Pharm Pharm Sci 2017;9(3):42-6.
